New Zealand markets close in 5 hours 32 minutes

Bio-Rad Laboratories, Inc. (BIO)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
476.94+7.25 (+1.54%)
At close: 04:04PM EST
476.94 +0.29 (+0.06%)
After hours: 04:04PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Total revenue
2,804,730
2,922,545
2,545,626
2,311,659
Cost of revenue
1,230,396
1,281,884
1,107,804
1,054,663
Gross profit
1,574,334
1,640,661
1,437,822
1,256,996
Operating expenses
Research development
269,399
271,657
226,598
202,710
Selling general and administrative
841,517
879,574
800,267
824,625
Total operating expenses
1,110,916
1,151,231
1,026,865
1,027,335
Operating income or loss
463,418
489,430
410,957
229,661
Interest expense
26,795
1,551
21,861
23,416
Total other income/expenses net
-8,323,555
4,931,395
4,500,354
2,024,342
Income before tax
-7,841,120
5,438,149
4,907,638
2,261,081
Income tax expense
-1,806,432
1,192,247
1,101,371
502,406
Income from continuing operations
-6,034,688
4,245,902
3,806,267
1,758,675
Net income
-6,034,688
4,245,902
3,806,267
1,758,675
Net income available to common shareholders
-6,034,688
4,245,902
3,806,267
1,758,675
Basic EPS
-
142.33
127.86
58.93
Diluted EPS
-
140.56
126.20
58.27
Basic average shares
-
29,831
29,768
29,843
Diluted average shares
-
30,208
30,160
30,184
EBITDA
-
5,573,500
5,067,599
2,418,697